bonalive
Bonalive Biomaterials is a medical technology company that develops and manufactures bioactive glass-based bone graft substitutes and related biomaterials used in orthopedics, spine surgery, and infection treatment. Its products are used by hospitals and surgeons to promote bone regeneration and treat chronic bone infections, generating revenue through the sale of implants and biomaterial products to healthcare providers and distributors worldwide.
- Revenue
- $12.0M
- Employees
- 60
- Founded
- 1993
- Headquarters
- Turku, Finland
What 5 Arbolus experts think of bonalive
NPS scores provided range from 2 (detractor) to 8 (promoter), with most responses in the neutral to positive range (7–8). Renewal intent is largely undetermined, with one influencer entering the pilot stage and expressing uncertainty. Stickiness is low, with most experts using Bonalive products for less than one year or being unsure about their implementation status. The overall pattern is that satisfaction is modest, with neither strong promoters nor clear intention to renew dominating sentiment.Overall Customer Sentiment: Neutral
Who reviewed bonalive
- C-Suite 60% (3)
- Director 40% (2)
Employer names and spend open once the report publishes.
Tell us when the bonalive report publishes.
We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.
Sentiment
-40 Net Promoter Score, from 5 scored reviews- Promoters 0
- Passives 3
- Detractors 2
Written answers and themes publish with the full report.
Renewal intent
Plan to renew 0%Plan to renew, by seniority
- 0% 1 answer
- 5/10 Average score from undecided customers
For people who use bonalive
Do you use bonalive at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 5 customers of bonalive have already contributed
Takes a few minutes. Your identity stays anonymous.